BEUDAMED
    15 results · 17ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Classification: FDA Class 2 ×

    SURG/ASSIST MODEL SA-1

    FDA 510(k)
    FDA Class 2 ·General, Plastic Surgery

    TOTIM Patient Cushion Immobilization System

    FDA 510(k)
    FDA Class 2 ·Radiology

    TECNO-GAZ ANDROMEDA VACUUM CS AUTOCLAVE

    FDA 510(k)
    FDA Class 2 ·General Hospital

    BASIC BIOFEEDBACK,TMG4.1, SA1/2, EEG4/5, IR RECEIV

    FDA 510(k)
    FDA Class 2 ·Neurology

    AUDIOMETER AI1, ME1 AND SA1 & MASTER HEARING AID

    FDA 510(k)
    FDA Class 2 ·Ear, Nose, Throat

    MicroScan Dried Gram-Negative MIC/Combo Panels with Ceftazidime (Caz) (0.5-64 µg/mL )

    FDA 510(k)
    FDA Class 2 ·Microbiology

    Fibrinogen And Split Products, Antigen, Antiserum, Control

    FDA classification
    FDA Class 2 ·Fibrinogen And Split Products, Antigen, Antiserum, Control

    Anesthesia Conduction Kit

    FDA classification
    FDA Class 2 ·Anesthesia Conduction Kit

    Sars-Cov-2 Serology Test

    FDA classification
    FDA Class 2 ·Sars-Cov-2 Serology Test

    Non-Sars Coronavirus Multiplex Nucleic Acid Assay

    FDA classification
    FDA Class 2 ·Non-Sars Coronavirus Multiplex Nucleic Acid Assay

    Respiratory Specimen Nucleic Acid Sars-Cov-2 Test

    FDA classification
    FDA Class 2 ·Respiratory Specimen Nucleic Acid Sars-Cov-2 Test

    Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens

    FDA classification
    FDA Class 2 ·Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens

    Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

    FDA classification
    FDA Class 2 ·Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

    Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

    FDA classification
    FDA Class 2 ·Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

    Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings

    FDA classification
    FDA Class 2 ·Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings